ReferencesvarHS/KN-kode 300360 er ikke omfattet til EUDR-forberedelse.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale Den indekserede anvendelsesområde-motor returnerer Out of scope for denne kode. No Annex I scope match was found for this indexed CN code.
Anvendelsesområde-grundlagHvorfor denne referenceside giver dette svar.
- Kodebeskrivelse
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale
- Bilag I-grundlag
- Ingen direkte bilag I-post
- Kildegrundlag
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
KN-hierarkiOverordnet, underordnet og nærliggende rækker.
Biblioteksvisningen er til referencenavigation. Brug tjekkeren, når du vil køre en anden kode som en handling.
30farmaceutiske produkterout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out30036000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout DokumentationsmønsterHvad dette betyder for forberedelsen.
Denne række udløser ikke direkte indsamling af dokumentation i det aktuelle anvendelsesområde-resultat.